PGR and breast cancer: However, there was no evidence of PR binding at the intron 2 element in leiomyoma patient samples (S9A and S9C Fig) while in breast cancer cell lines, there is strong evidence for PR binding to the Intron 2 regulatory element (S9A and S9D Fig).